Back
Bright Minds Biosciences 10K Form
Sell
30
DRUG
Bright Minds Biosciences
Last Price:
$39.95
Seasonality Move:
-40.69%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive DRUG News And Ratings
See the #1 stock for the next 7 days that we like better than DRUG
DRUG Financial Statistics
Sales & Book Value
Annual Sales: | -- |
---|---|
Cash Flow: | $193K |
Price / Cash Flow: | 0 |
Annual Sales: | $1.00 |
Price / Book: | 58.94 |
Profitability
EPS (TTM): | -0.68110 |
---|---|
Net Income (TTM): | $-2.6M |
Gross Margin: | -- |
Return on Equity: | 0% |
Return on Assets: | 0% |
Bright Minds Biosciences Earnings Forecast
Key Bright Minds Biosciences Financial Ratios
-
Per Share Earnings over the last 4 years have been positive in 1 years.
Bright Minds Biosciences Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | DRUG |
Website: | brightmindsbio.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
DRUG Technical Analysis vs Fundamental Analysis
Sell
30
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy or a Sell?
-
Bright Minds Biosciences stock is rated a SellThe current Bright Minds Biosciences [DRUG] share price is $37.63. The Score for DRUG is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.